| Secretin-enhanced Magnetic Resonance Imaging (S-MRI) for Pancreatic Cancer Detection (NCT01094626) | Elizabeth Hecht | 2010-04-01 |
| Immunotherapy Study for Surgically Resected Pancreatic Cancer (NCT01072981) | NewLink Genetics Corporation | 2010-04-01 |
| Efficacy and Safety Study of LE-DT to Treat Locally Advanced or Metastatic Pancreatic Cancer (NCT01186731) | INSYS Therapeutics Inc | 2010-04-01 |
| Dalteparin for Primary Venous Thromboembolism (VTE) Prophylaxis in Pancreatic Cancer Patients (NCT00966277) | M.D. Anderson Cancer Center | 2010-04-01 |
| Comparing Parenteral Nutrition vs Best Supportive Nutritional Care in Patients With Pancreatic Cancer (NCT01362582) | National Center for Tumor Diseases, Heidelberg | 2010-03-01 |
| Identify the Clinical Significance and Potential Implications of Peritoneal Washing Cytology (PWC) in Patients With Pancreatic Cancer (NCT01127815) | National Taiwan University Hospital | 2010-03-01 |
| Gabapentin and Risk of Pancreatic Cancer and Renal Cancer (GPRD) (NCT01138124) | GlaxoSmithKline | 2010-03-01 |
| Endoscopic Bipolar Radiofrequency Probe (ENDOHPB) in the Management of Unresectable Bile Duct and Pancreatic Cancer (NCT01303159) | Weill Medical College of Cornell University | 2010-03-01 |
| Prognostic Value of Baseline Computed Tomography (CT) Perfusion Parameters of Pancreatic Cancer for Patients Undergoing Stereotactic Body Radiotherapy or Surgical Resection (NCT01326364) | Stanford University | 2010-03-01 |
| Study of S-1 as Second Line Treatment on Advanced Pancreatic Cancers (NCT01074996) | The Affiliated Hospital of the Chinese Academy of Military Medical Sciences | 2010-02-01 |
| Randomized Trial of Restrictive Versus Liberal Perioperative Fluid Management for Patients Undergoing Pancreatic Resection (NCT01058746) | Memorial Sloan Kettering Cancer Center | 2010-01-01 |
| A Randomised Trial With Irinotecan, Cetuximab and Everolimus (ICE)Compared to Capecitabine and Oxaliplatin (CapOx) for Patients With Gemcitabin Resistant Pancreatic Cancer (NCT01042028) | Per Pfeiffer | 2010-01-01 |
| Pancreatic Surgery in Elderly Patients (NCT04893408) | Rigshospitalet, Denmark | 2010-01-01 |
| Collection of Biospecimen & Clinical Information in Patients w/ Gastrointestinal Cancers (NCT01031056) | Stanford University | 2010-01-01 |
| Comparing Covered Self-expandable Metallic Stent (SEMS) Above/Across the Sphincter of Oddi (NCT01041612) | Taewoong Medical Co., Ltd. | 2010-01-01 |
| Trial Comparing Two Techniques of Celiac Plexus Neurolysis for Treatment of Pain in Carcinoma Pancreas (NCT01182831) | Asian Institute of Gastroenterology, India | 2010-01-01 |
| Neoadjuvant Accelerated Short Course Radiation Therapy With Photons and Capecitabine for Resectable Pancreatic Cancer (NCT00889187) | Dana-Farber Cancer Institute | 2009-12-01 |
| Study of Pazopanib and Ixabepilone in Patients With Solid Tumors (NCT01012362) | Masonic Cancer Center, University of Minnesota | 2009-12-01 |
| Plastic vs. Covered Metal vs. Uncovered Metal Biliary Stents for the Management of Malignant Biliary Obstruction (NCT01038713) | Dartmouth-Hitchcock Medical Center | 2009-12-01 |
| Safety Study of a Liposomal Docetaxel Formulation in Patients With Solid Tumors Who Have Failed Previous Therapies (NCT01041235) | Azaya Therapeutics, Inc. | 2009-12-01 |
| Study of Safety and Tolerability of PCI-27483 in Patients With Pancreatic Cancer Patients Receiving Treatment With Gemcitabine (NCT01020006) | Pharmacyclics LLC. | 2009-11-01 |
| A Study of Gemcitabine and Cyberknife Radiation Therapy for Pancreatic Cancer (NCT01051284) | Georgetown University | 2009-11-01 |
| Gemcitabine Hydrochloride, Oxaliplatin, and Erlotinib Hydrochloride in Treating Patients With Advanced Biliary Tract Cancer, Pancreatic Cancer, Duodenal Cancer, or Ampullary Cancer (NCT00987766) | Vanderbilt-Ingram Cancer Center | 2009-11-01 |
| Administration of GRASPA (Suspension of Erythrocytes Encapsulating L-asparaginase)in Patients With Pancreatic Cancer (NCT01523808) | ERYtech Pharma | 2009-11-01 |
| Margin-Intense Combo Therapy in Pts w/Potentially Resectable Pancreatic Cancer (NCT01025882) | University of Texas Southwestern Medical Center | 2009-10-01 |
| Capecitabine, Vorinostat, and Radiation Therapy in Treating Patients With Nonmetastatic Pancreatic Cancer (NCT00983268) | Vanderbilt-Ingram Cancer Center | 2009-10-01 |
| Placebo Controlled Trial of SOM230 for the Reduction of Post-Pancreatectomy Fistula, Leak, and Abscess (NCT00994110) | Memorial Sloan Kettering Cancer Center | 2009-10-01 |
| Phase II Gemcitabine + Fractionated Stereotactic Radiotherapy for Unresectable Pancreatic Adenocarcinoma (NCT01146054) | Stanford University | 2009-10-01 |
| Frequency of Methods of Local Invasion of Pancreatic Adenocarcinoma (NCT01129167) | Columbia University | 2009-09-15 |
| Use of PET Imaging to Distinguish Malignant From Benign IPMN (NCT01104116) | Columbia University | 2009-09-01 |
| Evaluate the Efficacy and Safety of Activated T-lymphocyte Cell Therapy in Advanced Pancreatic Cancer (NCT00965718) | GC Cell Corporation | 2009-09-01 |
| Palonosetron Hydrochloride in Preventing Nausea and Vomiting Caused by Radiation Therapy in Patients With Primary Abdominal Cancer (NCT00903396) | Alliance for Clinical Trials in Oncology | 2009-09-01 |
| Adjuvant Versus Neoadjuvant Plus Adjuvant Chemotherapy in Resectable Pancreatic Cancer (NCT01314027) | University of Zurich | 2009-09-01 |
| Contrast Enhanced EUS in the Evaluation of Pancreatic Cancer and Pancreatic Masses (NCT01703026) | Changi General Hospital | 2009-08-01 |
| Resection in Pancreatic Cancer With Minimal Metastatic Disease or Venous Infiltration Trial at Technische Universität München (NCT00855634) | Technical University of Munich | 2009-08-01 |
| Vorinostat With XRT and 5-FU for Locally Advanced Adenocarcinoma of the Pancreas (NCT00948688) | Massachusetts General Hospital | 2009-08-01 |
| Stool Testing for Pancreatic Cancer (NCT01104129) | Columbia University | 2009-07-09 |
| 177Lu-J591 Antibody in Patients With Nonprostate Metastatic Solid Tumors (NCT00967577) | Weill Medical College of Cornell University | 2009-07-01 |
| Gemcitabine, Capecitabine, and Radiation Therapy in Treating Patients With Locally Advanced Pancreatic Cancer That Cannot Be Removed by Surgery (NCT01032057) | Lisette Nixon | 2009-07-01 |
| Panitumumab, Chemotherapy, and External-Beam Radiation Therapy in Treating Patients With Locally Advanced Pancreatic Cancer That Cannot be Removed by Surgery (NCT00601627) | Alliance for Clinical Trials in Oncology | 2009-06-01 |
| Acceptability of Less Harmful Alternatives to Cigarettes (NCT00957424) | Roswell Park Cancer Institute | 2009-06-01 |
| Endoscopic Ultrasound (EUS) Guided-Celiac Plexus Neurolysis (CPN) in Unresectable Pancreatic Cancer (NCT00968175) | University of Alabama at Birmingham | 2009-06-01 |
| Safety and Efficacy Study of P276-00 in Combination With Gemcitabine in Patients With Advanced Pancreatic Cancer (NCT00898287) | Piramal Enterprises Limited | 2009-05-01 |
| A Phase I/II Open-Label Dose-Escalation Clinical Trial of CPI-613 in Combination With Gemcitabine in Cancer Patients (NCT00907166) | Cornerstone Pharmaceuticals | 2009-05-01 |
| Vorinostat Plus Radiation Therapy in Pancreatic Cancer (NCT00831493) | M.D. Anderson Cancer Center | 2009-05-01 |
| Effects of Preoperative Immunonutrition in Patients Undergoing Pancreaticoduodenectomy (NCT01256034) | Chiba University | 2009-05-01 |
| Safety and Effectiveness Study of Autologous Natural Killer and Natural Killer T Cells on Cancer (NCT00909558) | Envita Medical Center, Inc. | 2009-05-01 |
| Genistein in Treating Patients With Pancreatic Cancer That Can Be Removed by Surgery (NCT00882765) | Jonsson Comprehensive Cancer Center | 2009-05-01 |
| Study of Stereotactic Body Radiation Therapy in Patients With Intact Pancreatic Cancer (NCT01342354) | University of Chicago | 2009-04-14 |
| Chemoradiotherapy With Gemcitabine/S-1 vs Gemcitabine/S-1 for Locally Advanced Pancreatic Cancer (NCT01430052) | Osaka Medical Center for Cancer and Cardiovascular Diseases | 2009-04-01 |
| Gemcitabine and Erlotinib in Treating Patients With Metastatic or Recurrent Pancreatic Cancer (NCT00810719) | University of California, Davis | 2009-04-01 |
| Intensity-Modulated Radiation Therapy and Gemcitabine in Treating Patients With Locally Advanced Pancreatic Cancer (NCT00878657) | Rutgers, The State University of New Jersey | 2009-04-01 |
| Gemcitabine and Erlotinib Before and After Surgery in Treating Patients With Pancreatic Cancer That Can Be Removed by Surgery (NCT00733746) | Alliance for Clinical Trials in Oncology | 2009-04-01 |
| A Study of AGS-1C4D4 Given in Combination With Gemcitabine in Subjects With Metastatic Pancreatic Cancer (NCT00902291) | Astellas Pharma Inc | 2009-04-01 |
| Pancreatic Intraepithelial Neoplasia (PanIN) and the Association With Recurrence of Pancreatic Adenocarcinoma (NCT01219829) | Columbia University | 2009-03-18 |
| Pioglitazone as Second-Line in Patients With Metastatic Pancreatic Cancer After Treatment With Gemcitabine (NCT00867126) | University of Texas Southwestern Medical Center | 2009-03-02 |
| A Clinical Study of UFT/Leucovorin, Radiotherapy With or Without Cetuximab Following Induction Gemcitabine Plus Capecitabine in Patients With Locally Advanced Pancreatic Cancer (PERU) (NCT01050426) | Royal Marsden NHS Foundation Trust | 2009-03-01 |
| A Study of ARRY-334543 and Gemcitabine in Patients With Advanced Cancer and Pancreatic Cancer (NCT00862524) | Array BioPharma | 2009-03-01 |
| Erlotinib and Gemcitabine With or Without Panitumumab in Treating Patients With Metastatic Pancreatic Cancer (NCT00550836) | Alliance for Clinical Trials in Oncology | 2009-03-01 |
| Validation of a Mouse Model of Pancreatic Carcinogenesis (NCT01103128) | Columbia University | 2009-03-01 |
| Proton Radiation for Resectable Carcinoma of the Pancreas (NCT00763516) | University of Florida | 2009-02-01 |
| 7 Day's of Erlotinib Neo-adjuvant, Followed by Adjuvant Erlotinib-gemcitabine in Pancreatic Cancer Patients (NCT00841035) | University of Alabama at Birmingham | 2009-02-01 |
| Ipilimumab +/- Vaccine Therapy in Treating Patients With Locally Advanced, Unresectable or Metastatic Pancreatic Cancer (NCT00836407) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2009-02-01 |
| Feasibility of Using Real-time Cine-MRI for Treating Moving & Deforming Tumors (NCT01071434) | Stanford University | 2009-02-01 |
| A Phase III Study of Pancreatic Cancer (NCT00994721) | National Health Research Institutes, Taiwan | 2009-02-01 |
| Prospective Analysis of Hypersensitivity Reactions to Oxaliplatin (NCT00831571) | Dana-Farber Cancer Institute | 2009-02-01 |
| Endoscopic Stenting Versus Surgical Bypass for Low Bile Duct Obstruction by Cancer of the Pancreatic Head (NCT00753441) | Heidelberg University | 2009-02-01 |
| QUILT-3.026: AMG 655 in Combination With AMG 479 in Advanced, Refractory Solid Tumors (NCT00819169) | NantCell, Inc. | 2009-01-16 |
| Fatigue and Pancreas and Bile Duct Cancer Study (NCT00902759) | Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University | 2009-01-09 |
| ATX Study:A Study of Avastin (Bevacizumab), Tarceva (Erlotinib) and Xeloda (Capecitabine) in Patients With Locally Advanced and/or Metastatic Pancreatic Cancer (NCT00925769) | Hoffmann-La Roche | 2009-01-01 |
| Lapatinib Ditosylate and Capecitabine in Treating Patients With Metastatic Pancreatic Cancer (NCT00962312) | Cancer Trials Ireland | 2009-01-01 |
| Long-term Survival Outcomes According to the Pathologic Response After Neoadjuvant Treatment in PDAC and the Fate of the Patients with Good CAP Grade (NCT06630481) | Seoul National University Hospital | 2009-01-01 |
| Opioid Growth Factor (OGF) and Gemcitabine: Novel Treatment for Pancreatic Cancer (NCT00783172) | Milton S. Hershey Medical Center | 2009-01-01 |
| Integrated Positron Emission Tomography - Computed Tomography (PET-CT) in Patients With Pancreatic Cancer (NCT00885248) | Asan Medical Center | 2009-01-01 |
| A Safety Study Using Pentamidine in Patients With Pancreatic Cancer Undergoing Standard Therapy (NCT00810953) | Oncozyme Pharma Inc. | 2009-01-01 |
| Quality of Life in Patients Undergoing Radiation Therapy for Primary Lung Cancer, Head and Neck Cancer, or Gastrointestinal Cancer (NCT00836992) | Mayo Clinic | 2009-01-01 |
| Cetuximab and Trastuzumab in Treating Patients With Metastatic Pancreatic Cancer That Progressed After Previous Treatment With Gemcitabine (NCT00923299) | Institut du Cancer de Montpellier - Val d'Aurelle | 2008-12-01 |
| Studying Pain and Symptom Distress in Patients With Advanced Colon Cancer, Rectal Cancer, Pancreatic Cancer, or Liver Cancer (NCT00950144) | City of Hope Medical Center | 2008-12-01 |
| Masitinib in Combination With Gemcitabine for Treatment of Patients With Advanced/Metastatic Pancreatic Cancer (NCT00789633) | AB Science | 2008-11-25 |
| Family and Personal History of Malignancy in Intraductal Papillary Mucinous Neoplasm (IPMN) (NCT01104077) | Columbia University | 2008-11-17 |
| MK-0646 and Gemcitabine +/- Erlotinib for Patients With Advanced Pancreatic Cancer (NCT00769483) | M.D. Anderson Cancer Center | 2008-11-13 |
| Identifying the Role of Symptom Outcomes and Biomarkers in Survival in Patients With Metastatic Pancreatic Cancer (NCT00805688) | M.D. Anderson Cancer Center | 2008-11-12 |
| Radiation Stent Versus Self-expanding Metallic Stents (SEMS) for Palliative Treatment of Malignant Biliary Stricture (NCT01320241) | Southeast University, China | 2008-11-01 |
| A Registry of Patients Undergoing Cellvizio Endomicroscopy and Endoscopic Retrograde Cholangiopancreatography(ERCP) Imaging Procedures for Diagnosing Pancreatic and Bile Duct Cancers (NCT00779688) | Mauna Kea Technologies | 2008-11-01 |
| B-Receptor Signaling in Cardiomyopathy (NCT01135849) | Daniel Bernstein | 2008-11-01 |
| Cyclooxygenase-2 Inhibitor for Adjuvant Anticancer Effect in Patients With Biliary-pancreas Cancer (NCT01111591) | Seoul National University Hospital | 2008-11-01 |
| Trial of Simvastatin and Gemcitabine in Pancreatic Cancer Patients (NCT00944463) | Samsung Medical Center | 2008-10-01 |
| Combination of Irinotecan, Oxaliplatin and Cetuximab for Locally Advanced or Metastatic Pancreatic Cancer (NCT00871169) | New Mexico Cancer Research Alliance | 2008-10-01 |
| Sorafenib and Erlotinib in Treating Patients With Pancreatic Cancer That Cannot Be Removed by Surgery (NCT00837876) | Vanderbilt-Ingram Cancer Center | 2008-10-01 |
| Stereotactic Body Radiotherapy for Unresectable Pancreatic Cancer (NCT01346410) | Mercy Research | 2008-09-01 |
| Preoperative Chemotherapy (Gemcitabine and Erlotinib) With or Without Radiation Therapy (NCT00766636) | M.D. Anderson Cancer Center | 2008-09-01 |
| Trial to Determine the Maximum Tolerated Dose of Genexol-PM Plus Gemcitabine and Evaluate Efficacy and Safety of Genexol-PM Regimens in Subjects With Advanced Pancreatic Cancer (NCT00882973) | Samyang Biopharmaceuticals Corporation | 2008-09-01 |
| Borderline Resectable Pancreatic Cancer: Gemcitabine/Docetaxel and Oxaliplatin Based Chemo/RT (NCT00761241) | Benaroya Research Institute | 2008-09-01 |
| Varenicline or Nicotine Patch and Nicotine Gum in Helping Smokers in a Methadone Treatment Program Stop Smoking (NCT00790569) | Butler Hospital | 2008-09-01 |
| Intraoperative Celiac Plexus Neurolysis for Patients With Operable Pancreatic and Periampullary Cancer (NCT00806611) | Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University | 2008-09-01 |
| Dose-Escalation Study of TH-302 in Combination With A) Gemcitabine or B) Docetaxel or C) Pemetrexed to Treat Advanced Solid Tumors (NCT00743379) | Threshold Pharmaceuticals | 2008-08-01 |
| Study of Blood Samples From Patients With Malignant Melanoma, Metastatic Breast Cancer, Advanced Lung Cancer, Pancreatic Cancer, or Colorectal Cancer. (NCT00974610) | Cancer Trials Ireland | 2008-08-01 |
| A Collection of Clinical and Epidemiologic Data Combined With Tissue and Blood From Patients With a Diagnosis of Neuroendocrine Tumors (NCT00745381) | Memorial Sloan Kettering Cancer Center | 2008-08-01 |
| Permission to Collect Blood Over Time for Research (NCT00767234) | Stanford University | 2008-08-01 |
| Creation of the BioBank, Early Detection and Discovery Biomarkers (NCT00901680) | Corewell Health East | 2008-08-01 |